nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—CA1—Imatinib—hematologic cancer	0.141	0.227	CbGbCtD
Methyclothiazide—CA1—Nilotinib—hematologic cancer	0.128	0.206	CbGbCtD
Methyclothiazide—CA2—Imatinib—hematologic cancer	0.122	0.196	CbGbCtD
Methyclothiazide—CA4—Nilotinib—hematologic cancer	0.121	0.194	CbGbCtD
Methyclothiazide—CA2—Nilotinib—hematologic cancer	0.111	0.178	CbGbCtD
Methyclothiazide—SLC12A1—hematopoietic system—hematologic cancer	0.00321	0.118	CbGeAlD
Methyclothiazide—SLC12A3—lung—hematologic cancer	0.00244	0.09	CbGeAlD
Methyclothiazide—CA1—hematopoietic system—hematologic cancer	0.00221	0.0814	CbGeAlD
Methyclothiazide—SLC12A1—blood—hematologic cancer	0.00213	0.0783	CbGeAlD
Methyclothiazide—SLC12A1—testis—hematologic cancer	0.00176	0.0648	CbGeAlD
Methyclothiazide—CA1—blood—hematologic cancer	0.00146	0.0539	CbGeAlD
Methyclothiazide—CA2—hematopoietic system—hematologic cancer	0.00143	0.0527	CbGeAlD
Methyclothiazide—CA1—bone marrow—hematologic cancer	0.00142	0.0522	CbGeAlD
Methyclothiazide—CA1—lung—hematologic cancer	0.00128	0.0473	CbGeAlD
Methyclothiazide—CA4—blood—hematologic cancer	0.00114	0.0421	CbGeAlD
Methyclothiazide—CA4—bone marrow—hematologic cancer	0.00111	0.0408	CbGeAlD
Methyclothiazide—Metolazone—CA9—hematologic cancer	0.00106	0.202	CrCbGaD
Methyclothiazide—CA4—lung—hematologic cancer	0.001	0.0369	CbGeAlD
Methyclothiazide—Benzthiazide—CA9—hematologic cancer	0.000956	0.183	CrCbGaD
Methyclothiazide—Diclofenamide—CA9—hematologic cancer	0.000949	0.181	CrCbGaD
Methyclothiazide—CA2—blood—hematologic cancer	0.000948	0.0349	CbGeAlD
Methyclothiazide—CA4—testis—hematologic cancer	0.000946	0.0348	CbGeAlD
Methyclothiazide—CA2—bone marrow—hematologic cancer	0.000918	0.0338	CbGeAlD
Methyclothiazide—CA1—lymph node—hematologic cancer	0.000877	0.0323	CbGeAlD
Methyclothiazide—CA2—lung—hematologic cancer	0.000831	0.0306	CbGeAlD
Methyclothiazide—Hydroflumethiazide—CA9—hematologic cancer	0.000801	0.153	CrCbGaD
Methyclothiazide—CA2—testis—hematologic cancer	0.000784	0.0289	CbGeAlD
Methyclothiazide—Hydrochlorothiazide—CA9—hematologic cancer	0.000779	0.149	CrCbGaD
Methyclothiazide—Trichlormethiazide—CA9—hematologic cancer	0.000694	0.133	CrCbGaD
Methyclothiazide—CA4—lymph node—hematologic cancer	0.000686	0.0253	CbGeAlD
Methyclothiazide—CA2—lymph node—hematologic cancer	0.000569	0.0209	CbGeAlD
Methyclothiazide—CA1—C-MYB transcription factor network—BIRC3—hematologic cancer	0.00047	0.0102	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—MYB—hematologic cancer	0.00047	0.0102	CbGpPWpGaD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000444	0.00968	CbGpPWpGaD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000403	0.00879	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—MPO—hematologic cancer	0.000402	0.00876	CbGpPWpGaD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000396	0.00863	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—GATA3—hematologic cancer	0.000363	0.0079	CbGpPWpGaD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.00036	0.00783	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—CDK6—hematologic cancer	0.000344	0.00749	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.00032	0.00698	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000298	0.00649	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000291	0.00634	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—KITLG—hematologic cancer	0.000274	0.00596	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.00027	0.00589	CbGpPWpGaD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000262	0.0057	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—HES1—hematologic cancer	0.000253	0.00551	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—NCOR1—hematologic cancer	0.000251	0.00548	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—GSTM1—hematologic cancer	0.000251	0.00548	CbGpPWpGaD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000247	0.00538	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000243	0.00529	CbGpPWpGaD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000238	0.00519	CbGpPWpGaD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000238	0.00518	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000226	0.00492	CbGpPWpGaD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000224	0.00489	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.00022	0.0048	CbGpPWpGaD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000216	0.00471	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000212	0.00462	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000205	0.00447	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000201	0.00438	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000193	0.0042	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—KIT—hematologic cancer	0.000187	0.00407	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000184	0.00401	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000184	0.00401	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000184	0.00401	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000183	0.00398	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—CREBBP—hematologic cancer	0.000173	0.00377	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000167	0.00364	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000167	0.00364	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000167	0.00364	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000166	0.00361	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—CDKN2A—hematologic cancer	0.000152	0.0033	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.00015	0.00328	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—BCL2—hematologic cancer	0.000149	0.00325	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000145	0.00317	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—CD4—hematologic cancer	0.000143	0.00311	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—CDKN1B—hematologic cancer	0.000134	0.00292	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000133	0.0029	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000132	0.00288	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—FTCD—hematologic cancer	0.000129	0.0028	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PHYH—hematologic cancer	0.000129	0.0028	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GMPS—hematologic cancer	0.000129	0.0028	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—CCND1—hematologic cancer	0.000128	0.00279	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000126	0.00274	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—CDKN1A—hematologic cancer	0.000124	0.0027	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GMPS—hematologic cancer	0.000123	0.00268	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—FTCD—hematologic cancer	0.000123	0.00268	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PHYH—hematologic cancer	0.000123	0.00268	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000122	0.00266	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000121	0.00264	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000121	0.00263	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000119	0.00258	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PHYH—hematologic cancer	0.000118	0.00257	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GMPS—hematologic cancer	0.000118	0.00257	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—FTCD—hematologic cancer	0.000118	0.00257	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—EP300—hematologic cancer	0.000118	0.00257	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—SMPD3—hematologic cancer	0.000118	0.00256	CbGpPWpGaD
Methyclothiazide—Dizziness—Thiotepa—hematologic cancer	0.000116	0.000387	CcSEcCtD
Methyclothiazide—Asthenia—Alitretinoin—hematologic cancer	0.000116	0.000386	CcSEcCtD
Methyclothiazide—Rash—Vinorelbine—hematologic cancer	0.000115	0.000386	CcSEcCtD
Methyclothiazide—Dermatitis—Vinorelbine—hematologic cancer	0.000115	0.000386	CcSEcCtD
Methyclothiazide—Headache—Vinorelbine—hematologic cancer	0.000115	0.000384	CcSEcCtD
Methyclothiazide—Hypersensitivity—Vincristine—hematologic cancer	0.000114	0.000382	CcSEcCtD
Methyclothiazide—Asthenia—Ifosfamide—hematologic cancer	0.000114	0.000382	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000114	0.00248	CbGpPWpGaD
Methyclothiazide—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000114	0.000381	CcSEcCtD
Methyclothiazide—Vertigo—Betamethasone—hematologic cancer	0.000114	0.00038	CcSEcCtD
Methyclothiazide—Vertigo—Dexamethasone—hematologic cancer	0.000114	0.00038	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Epirubicin—hematologic cancer	0.000113	0.000378	CcSEcCtD
Methyclothiazide—Paraesthesia—Etoposide—hematologic cancer	0.000113	0.000377	CcSEcCtD
Methyclothiazide—CA2—Metabolism—SMPD3—hematologic cancer	0.000113	0.00246	CbGpPWpGaD
Methyclothiazide—Pancreatitis—Doxorubicin—hematologic cancer	0.000112	0.000376	CcSEcCtD
Methyclothiazide—Dizziness—Thalidomide—hematologic cancer	0.000112	0.000374	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Epirubicin—hematologic cancer	0.000112	0.000373	CcSEcCtD
Methyclothiazide—Nausea—Bortezomib—hematologic cancer	0.000111	0.000372	CcSEcCtD
Methyclothiazide—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000111	0.000372	CcSEcCtD
Methyclothiazide—Hypersensitivity—Irinotecan—hematologic cancer	0.000111	0.000372	CcSEcCtD
Methyclothiazide—Asthenia—Vincristine—hematologic cancer	0.000111	0.000372	CcSEcCtD
Methyclothiazide—Paraesthesia—Prednisolone—hematologic cancer	0.000111	0.000372	CcSEcCtD
Methyclothiazide—Vomiting—Thiotepa—hematologic cancer	0.000111	0.000372	CcSEcCtD
Methyclothiazide—Diarrhoea—Carmustine—hematologic cancer	0.000111	0.000372	CcSEcCtD
Methyclothiazide—Pneumonia—Epirubicin—hematologic cancer	0.000111	0.000371	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000111	0.00241	CbGpPWpGaD
Methyclothiazide—Nausea—Bleomycin—hematologic cancer	0.000111	0.00037	CcSEcCtD
Methyclothiazide—Malnutrition—Prednisone—hematologic cancer	0.00011	0.000369	CcSEcCtD
Methyclothiazide—Rash—Thiotepa—hematologic cancer	0.00011	0.000369	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—NRAS—hematologic cancer	0.00011	0.0024	CbGpPWpGaD
Methyclothiazide—Dermatitis—Thiotepa—hematologic cancer	0.00011	0.000368	CcSEcCtD
Methyclothiazide—Diarrhoea—Alitretinoin—hematologic cancer	0.00011	0.000368	CcSEcCtD
Methyclothiazide—Agranulocytosis—Methotrexate—hematologic cancer	0.00011	0.000368	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.00011	0.00239	CbGpPWpGaD
Methyclothiazide—Headache—Thiotepa—hematologic cancer	0.00011	0.000366	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	0.000109	0.000366	CcSEcCtD
Methyclothiazide—Decreased appetite—Etoposide—hematologic cancer	0.000109	0.000365	CcSEcCtD
Methyclothiazide—Diarrhoea—Ifosfamide—hematologic cancer	0.000109	0.000364	CcSEcCtD
Methyclothiazide—Nausea—Vinorelbine—hematologic cancer	0.000109	0.000364	CcSEcCtD
Methyclothiazide—Body temperature increased—Cisplatin—hematologic cancer	0.000108	0.000362	CcSEcCtD
Methyclothiazide—Asthenia—Irinotecan—hematologic cancer	0.000108	0.000362	CcSEcCtD
Methyclothiazide—Asthenia—Mitoxantrone—hematologic cancer	0.000108	0.000362	CcSEcCtD
Methyclothiazide—CA1—Metabolism—SMPD3—hematologic cancer	0.000108	0.00235	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000108	0.00235	CbGpPWpGaD
Methyclothiazide—Jaundice—Epirubicin—hematologic cancer	0.000108	0.00036	CcSEcCtD
Methyclothiazide—Vomiting—Thalidomide—hematologic cancer	0.000108	0.00036	CcSEcCtD
Methyclothiazide—Dizziness—Carmustine—hematologic cancer	0.000107	0.000359	CcSEcCtD
Methyclothiazide—Constipation—Etoposide—hematologic cancer	0.000107	0.000359	CcSEcCtD
Methyclothiazide—Rash—Thalidomide—hematologic cancer	0.000107	0.000357	CcSEcCtD
Methyclothiazide—Dermatitis—Thalidomide—hematologic cancer	0.000107	0.000356	CcSEcCtD
Methyclothiazide—Dizziness—Alitretinoin—hematologic cancer	0.000106	0.000356	CcSEcCtD
Methyclothiazide—Diarrhoea—Vincristine—hematologic cancer	0.000106	0.000355	CcSEcCtD
Methyclothiazide—Headache—Thalidomide—hematologic cancer	0.000106	0.000354	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000106	0.0023	CbGpPWpGaD
Methyclothiazide—Asthenia—Gemcitabine—hematologic cancer	0.000106	0.000353	CcSEcCtD
Methyclothiazide—Dizziness—Ifosfamide—hematologic cancer	0.000105	0.000352	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Doxorubicin—hematologic cancer	0.000105	0.00035	CcSEcCtD
Methyclothiazide—Vision blurred—Prednisone—hematologic cancer	0.000104	0.000348	CcSEcCtD
Methyclothiazide—Nausea—Thiotepa—hematologic cancer	0.000104	0.000347	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000103	0.000346	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Betamethasone—hematologic cancer	0.000103	0.000346	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Doxorubicin—hematologic cancer	0.000103	0.000346	CcSEcCtD
Methyclothiazide—Diarrhoea—Mitoxantrone—hematologic cancer	0.000103	0.000345	CcSEcCtD
Methyclothiazide—Diarrhoea—Irinotecan—hematologic cancer	0.000103	0.000345	CcSEcCtD
Methyclothiazide—Vomiting—Carmustine—hematologic cancer	0.000103	0.000345	CcSEcCtD
Methyclothiazide—Agranulocytosis—Epirubicin—hematologic cancer	0.000103	0.000344	CcSEcCtD
Methyclothiazide—Pneumonia—Doxorubicin—hematologic cancer	0.000103	0.000344	CcSEcCtD
Methyclothiazide—CA4—Metabolism—B3GAT1—hematologic cancer	0.000103	0.00224	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ASNS—hematologic cancer	0.000103	0.00224	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—DCK—hematologic cancer	0.000103	0.00224	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—MYC—hematologic cancer	0.000103	0.00224	CbGpPWpGaD
Methyclothiazide—Dizziness—Vincristine—hematologic cancer	0.000103	0.000343	CcSEcCtD
Methyclothiazide—Rash—Carmustine—hematologic cancer	0.000102	0.000342	CcSEcCtD
Methyclothiazide—Dermatitis—Carmustine—hematologic cancer	0.000102	0.000342	CcSEcCtD
Methyclothiazide—Vomiting—Alitretinoin—hematologic cancer	0.000102	0.000342	CcSEcCtD
Methyclothiazide—Paraesthesia—Triamcinolone—hematologic cancer	0.000102	0.000342	CcSEcCtD
Methyclothiazide—Headache—Carmustine—hematologic cancer	0.000102	0.00034	CcSEcCtD
Methyclothiazide—Rash—Alitretinoin—hematologic cancer	0.000102	0.000339	CcSEcCtD
Methyclothiazide—Agitation—Prednisone—hematologic cancer	0.000101	0.000339	CcSEcCtD
Methyclothiazide—Dermatitis—Alitretinoin—hematologic cancer	0.000101	0.000339	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	0.000101	0.000339	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Betamethasone—hematologic cancer	0.000101	0.000338	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Dexamethasone—hematologic cancer	0.000101	0.000338	CcSEcCtD
Methyclothiazide—Vomiting—Ifosfamide—hematologic cancer	0.000101	0.000338	CcSEcCtD
Methyclothiazide—Hypersensitivity—Cisplatin—hematologic cancer	0.000101	0.000338	CcSEcCtD
Methyclothiazide—Headache—Alitretinoin—hematologic cancer	0.000101	0.000337	CcSEcCtD
Methyclothiazide—Diarrhoea—Gemcitabine—hematologic cancer	0.000101	0.000336	CcSEcCtD
Methyclothiazide—Nausea—Thalidomide—hematologic cancer	0.000101	0.000336	CcSEcCtD
Methyclothiazide—Rash—Ifosfamide—hematologic cancer	0.0001	0.000335	CcSEcCtD
Methyclothiazide—Dermatitis—Ifosfamide—hematologic cancer	0.0001	0.000335	CcSEcCtD
Methyclothiazide—Erythema multiforme—Methotrexate—hematologic cancer	0.0001	0.000335	CcSEcCtD
Methyclothiazide—Dizziness—Irinotecan—hematologic cancer	9.99e-05	0.000334	CcSEcCtD
Methyclothiazide—Urticaria—Etoposide—hematologic cancer	9.98e-05	0.000334	CcSEcCtD
Methyclothiazide—Jaundice—Doxorubicin—hematologic cancer	9.96e-05	0.000333	CcSEcCtD
Methyclothiazide—Body temperature increased—Etoposide—hematologic cancer	9.93e-05	0.000332	CcSEcCtD
Methyclothiazide—Vertigo—Prednisone—hematologic cancer	9.91e-05	0.000331	CcSEcCtD
Methyclothiazide—Vomiting—Vincristine—hematologic cancer	9.86e-05	0.00033	CcSEcCtD
Methyclothiazide—Anorexia—Dexamethasone—hematologic cancer	9.86e-05	0.000329	CcSEcCtD
Methyclothiazide—Anorexia—Betamethasone—hematologic cancer	9.86e-05	0.000329	CcSEcCtD
Methyclothiazide—CA2—Metabolism—DCK—hematologic cancer	9.85e-05	0.00215	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ASNS—hematologic cancer	9.85e-05	0.00215	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—B3GAT1—hematologic cancer	9.85e-05	0.00215	CbGpPWpGaD
Methyclothiazide—Urticaria—Prednisolone—hematologic cancer	9.85e-05	0.000329	CcSEcCtD
Methyclothiazide—Asthenia—Cisplatin—hematologic cancer	9.84e-05	0.000329	CcSEcCtD
Methyclothiazide—Rash—Vincristine—hematologic cancer	9.78e-05	0.000327	CcSEcCtD
Methyclothiazide—Dermatitis—Vincristine—hematologic cancer	9.77e-05	0.000327	CcSEcCtD
Methyclothiazide—CA4—Metabolism—HDC—hematologic cancer	9.74e-05	0.00212	CbGpPWpGaD
Methyclothiazide—Headache—Vincristine—hematologic cancer	9.72e-05	0.000325	CcSEcCtD
Methyclothiazide—Nausea—Carmustine—hematologic cancer	9.65e-05	0.000323	CcSEcCtD
Methyclothiazide—Vomiting—Mitoxantrone—hematologic cancer	9.61e-05	0.000321	CcSEcCtD
Methyclothiazide—Vomiting—Irinotecan—hematologic cancer	9.61e-05	0.000321	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—TFRC—hematologic cancer	9.6e-05	0.00209	CbGpPWpGaD
Methyclothiazide—Nausea—Alitretinoin—hematologic cancer	9.56e-05	0.00032	CcSEcCtD
Methyclothiazide—Agranulocytosis—Doxorubicin—hematologic cancer	9.54e-05	0.000319	CcSEcCtD
Methyclothiazide—Rash—Irinotecan—hematologic cancer	9.53e-05	0.000318	CcSEcCtD
Methyclothiazide—Rash—Mitoxantrone—hematologic cancer	9.53e-05	0.000318	CcSEcCtD
Methyclothiazide—Dermatitis—Irinotecan—hematologic cancer	9.52e-05	0.000318	CcSEcCtD
Methyclothiazide—Dermatitis—Mitoxantrone—hematologic cancer	9.52e-05	0.000318	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—KRAS—hematologic cancer	9.49e-05	0.00207	CbGpPWpGaD
Methyclothiazide—Headache—Irinotecan—hematologic cancer	9.46e-05	0.000316	CcSEcCtD
Methyclothiazide—Headache—Mitoxantrone—hematologic cancer	9.46e-05	0.000316	CcSEcCtD
Methyclothiazide—Nausea—Ifosfamide—hematologic cancer	9.45e-05	0.000316	CcSEcCtD
Methyclothiazide—CA1—Metabolism—ASNS—hematologic cancer	9.45e-05	0.00206	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—DCK—hematologic cancer	9.45e-05	0.00206	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—B3GAT1—hematologic cancer	9.45e-05	0.00206	CbGpPWpGaD
Methyclothiazide—Diarrhoea—Cisplatin—hematologic cancer	9.39e-05	0.000314	CcSEcCtD
Methyclothiazide—Erythema multiforme—Epirubicin—hematologic cancer	9.37e-05	0.000313	CcSEcCtD
Methyclothiazide—Vomiting—Gemcitabine—hematologic cancer	9.36e-05	0.000313	CcSEcCtD
Methyclothiazide—CA2—Metabolism—HDC—hematologic cancer	9.34e-05	0.00203	CbGpPWpGaD
Methyclothiazide—Paraesthesia—Dexamethasone—hematologic cancer	9.29e-05	0.00031	CcSEcCtD
Methyclothiazide—Paraesthesia—Betamethasone—hematologic cancer	9.29e-05	0.00031	CcSEcCtD
Methyclothiazide—Rash—Gemcitabine—hematologic cancer	9.28e-05	0.00031	CcSEcCtD
Methyclothiazide—Dermatitis—Gemcitabine—hematologic cancer	9.27e-05	0.00031	CcSEcCtD
Methyclothiazide—Hypersensitivity—Etoposide—hematologic cancer	9.26e-05	0.000309	CcSEcCtD
Methyclothiazide—Malnutrition—Methotrexate—hematologic cancer	9.22e-05	0.000308	CcSEcCtD
Methyclothiazide—Headache—Gemcitabine—hematologic cancer	9.22e-05	0.000308	CcSEcCtD
Methyclothiazide—Nausea—Vincristine—hematologic cancer	9.21e-05	0.000308	CcSEcCtD
Methyclothiazide—Hypersensitivity—Prednisolone—hematologic cancer	9.13e-05	0.000305	CcSEcCtD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	9.11e-05	0.00198	CbGpPWpGaD
Methyclothiazide—Urticaria—Triamcinolone—hematologic cancer	9.05e-05	0.000303	CcSEcCtD
Methyclothiazide—Asthenia—Etoposide—hematologic cancer	9.02e-05	0.000301	CcSEcCtD
Methyclothiazide—Body temperature increased—Triamcinolone—hematologic cancer	9.01e-05	0.000301	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Prednisone—hematologic cancer	9.01e-05	0.000301	CcSEcCtD
Methyclothiazide—Decreased appetite—Betamethasone—hematologic cancer	8.99e-05	0.0003	CcSEcCtD
Methyclothiazide—Decreased appetite—Dexamethasone—hematologic cancer	8.99e-05	0.0003	CcSEcCtD
Methyclothiazide—Nausea—Mitoxantrone—hematologic cancer	8.97e-05	0.0003	CcSEcCtD
Methyclothiazide—Nausea—Irinotecan—hematologic cancer	8.97e-05	0.0003	CcSEcCtD
Methyclothiazide—CA1—Metabolism—HDC—hematologic cancer	8.95e-05	0.00195	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CDA—hematologic cancer	8.91e-05	0.00194	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	8.87e-05	0.00193	CbGpPWpGaD
Methyclothiazide—Nausea—Gemcitabine—hematologic cancer	8.74e-05	0.000292	CcSEcCtD
Methyclothiazide—Vomiting—Cisplatin—hematologic cancer	8.72e-05	0.000291	CcSEcCtD
Methyclothiazide—Vision blurred—Methotrexate—hematologic cancer	8.69e-05	0.00029	CcSEcCtD
Methyclothiazide—Erythema multiforme—Doxorubicin—hematologic cancer	8.67e-05	0.00029	CcSEcCtD
Methyclothiazide—Rash—Cisplatin—hematologic cancer	8.65e-05	0.000289	CcSEcCtD
Methyclothiazide—Dermatitis—Cisplatin—hematologic cancer	8.64e-05	0.000289	CcSEcCtD
Methyclothiazide—Malnutrition—Epirubicin—hematologic cancer	8.63e-05	0.000288	CcSEcCtD
Methyclothiazide—Diarrhoea—Etoposide—hematologic cancer	8.6e-05	0.000287	CcSEcCtD
Methyclothiazide—Anorexia—Prednisone—hematologic cancer	8.59e-05	0.000287	CcSEcCtD
Methyclothiazide—CA4—Metabolism—PC—hematologic cancer	8.58e-05	0.00187	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CDA—hematologic cancer	8.54e-05	0.00186	CbGpPWpGaD
Methyclothiazide—Hypersensitivity—Triamcinolone—hematologic cancer	8.4e-05	0.000281	CcSEcCtD
Methyclothiazide—Dizziness—Etoposide—hematologic cancer	8.31e-05	0.000278	CcSEcCtD
Methyclothiazide—Muscle spasms—Epirubicin—hematologic cancer	8.3e-05	0.000277	CcSEcCtD
Methyclothiazide—Vertigo—Methotrexate—hematologic cancer	8.29e-05	0.000277	CcSEcCtD
Methyclothiazide—CA4—Metabolism—SLC35B2—hematologic cancer	8.28e-05	0.0018	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GBA—hematologic cancer	8.28e-05	0.0018	CbGpPWpGaD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—ALB—hematologic cancer	8.27e-05	0.0018	CbGpPWpGaD
Methyclothiazide—Leukopenia—Methotrexate—hematologic cancer	8.26e-05	0.000276	CcSEcCtD
Methyclothiazide—CA2—Metabolism—PC—hematologic cancer	8.22e-05	0.00179	CbGpPWpGaD
Methyclothiazide—Urticaria—Dexamethasone—hematologic cancer	8.22e-05	0.000275	CcSEcCtD
Methyclothiazide—Urticaria—Betamethasone—hematologic cancer	8.22e-05	0.000275	CcSEcCtD
Methyclothiazide—Dizziness—Prednisolone—hematologic cancer	8.2e-05	0.000274	CcSEcCtD
Methyclothiazide—CA1—Metabolism—CDA—hematologic cancer	8.19e-05	0.00178	CbGpPWpGaD
Methyclothiazide—Asthenia—Triamcinolone—hematologic cancer	8.18e-05	0.000273	CcSEcCtD
Methyclothiazide—Body temperature increased—Dexamethasone—hematologic cancer	8.18e-05	0.000273	CcSEcCtD
Methyclothiazide—Body temperature increased—Betamethasone—hematologic cancer	8.18e-05	0.000273	CcSEcCtD
Methyclothiazide—Nausea—Cisplatin—hematologic cancer	8.15e-05	0.000272	CcSEcCtD
Methyclothiazide—Vision blurred—Epirubicin—hematologic cancer	8.13e-05	0.000272	CcSEcCtD
Methyclothiazide—Paraesthesia—Prednisone—hematologic cancer	8.09e-05	0.00027	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—HRAS—hematologic cancer	8.07e-05	0.00176	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—CYCS—hematologic cancer	8.05e-05	0.00175	CbGpPWpGaD
Methyclothiazide—Vomiting—Etoposide—hematologic cancer	7.99e-05	0.000267	CcSEcCtD
Methyclothiazide—Malnutrition—Doxorubicin—hematologic cancer	7.99e-05	0.000267	CcSEcCtD
Methyclothiazide—CA2—Metabolism—GBA—hematologic cancer	7.94e-05	0.00173	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—SLC35B2—hematologic cancer	7.94e-05	0.00173	CbGpPWpGaD
Methyclothiazide—Agitation—Epirubicin—hematologic cancer	7.93e-05	0.000265	CcSEcCtD
Methyclothiazide—Rash—Etoposide—hematologic cancer	7.92e-05	0.000265	CcSEcCtD
Methyclothiazide—Dermatitis—Etoposide—hematologic cancer	7.92e-05	0.000265	CcSEcCtD
Methyclothiazide—CA1—Metabolism—PC—hematologic cancer	7.88e-05	0.00172	CbGpPWpGaD
Methyclothiazide—Headache—Etoposide—hematologic cancer	7.87e-05	0.000263	CcSEcCtD
Methyclothiazide—Decreased appetite—Prednisone—hematologic cancer	7.83e-05	0.000262	CcSEcCtD
Methyclothiazide—Rash—Prednisolone—hematologic cancer	7.81e-05	0.000261	CcSEcCtD
Methyclothiazide—Dermatitis—Prednisolone—hematologic cancer	7.81e-05	0.000261	CcSEcCtD
Methyclothiazide—Headache—Prednisolone—hematologic cancer	7.76e-05	0.000259	CcSEcCtD
Methyclothiazide—Vertigo—Epirubicin—hematologic cancer	7.75e-05	0.000259	CcSEcCtD
Methyclothiazide—Leukopenia—Epirubicin—hematologic cancer	7.73e-05	0.000258	CcSEcCtD
Methyclothiazide—Constipation—Prednisone—hematologic cancer	7.7e-05	0.000257	CcSEcCtD
Methyclothiazide—Muscle spasms—Doxorubicin—hematologic cancer	7.68e-05	0.000257	CcSEcCtD
Methyclothiazide—CA1—Metabolism—GBA—hematologic cancer	7.61e-05	0.00166	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—SLC35B2—hematologic cancer	7.61e-05	0.00166	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—MTAP—hematologic cancer	7.58e-05	0.00165	CbGpPWpGaD
Methyclothiazide—Dizziness—Triamcinolone—hematologic cancer	7.54e-05	0.000252	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Methotrexate—hematologic cancer	7.53e-05	0.000252	CcSEcCtD
Methyclothiazide—Vision blurred—Doxorubicin—hematologic cancer	7.53e-05	0.000252	CcSEcCtD
Methyclothiazide—Nausea—Etoposide—hematologic cancer	7.46e-05	0.000249	CcSEcCtD
Methyclothiazide—Asthenia—Betamethasone—hematologic cancer	7.42e-05	0.000248	CcSEcCtD
Methyclothiazide—Asthenia—Dexamethasone—hematologic cancer	7.42e-05	0.000248	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	7.4e-05	0.00161	CbGpPWpGaD
Methyclothiazide—Thrombocytopenia—Methotrexate—hematologic cancer	7.37e-05	0.000246	CcSEcCtD
Methyclothiazide—Nausea—Prednisolone—hematologic cancer	7.36e-05	0.000246	CcSEcCtD
Methyclothiazide—Agitation—Doxorubicin—hematologic cancer	7.34e-05	0.000245	CcSEcCtD
Methyclothiazide—CA2—Metabolism—MTAP—hematologic cancer	7.26e-05	0.00158	CbGpPWpGaD
Methyclothiazide—Vomiting—Triamcinolone—hematologic cancer	7.25e-05	0.000242	CcSEcCtD
Methyclothiazide—Rash—Triamcinolone—hematologic cancer	7.19e-05	0.00024	CcSEcCtD
Methyclothiazide—Dermatitis—Triamcinolone—hematologic cancer	7.18e-05	0.00024	CcSEcCtD
Methyclothiazide—Vertigo—Doxorubicin—hematologic cancer	7.18e-05	0.00024	CcSEcCtD
Methyclothiazide—Anorexia—Methotrexate—hematologic cancer	7.17e-05	0.00024	CcSEcCtD
Methyclothiazide—Urticaria—Prednisone—hematologic cancer	7.16e-05	0.000239	CcSEcCtD
Methyclothiazide—Leukopenia—Doxorubicin—hematologic cancer	7.15e-05	0.000239	CcSEcCtD
Methyclothiazide—Headache—Triamcinolone—hematologic cancer	7.14e-05	0.000239	CcSEcCtD
Methyclothiazide—Body temperature increased—Prednisone—hematologic cancer	7.12e-05	0.000238	CcSEcCtD
Methyclothiazide—Diarrhoea—Betamethasone—hematologic cancer	7.08e-05	0.000236	CcSEcCtD
Methyclothiazide—Diarrhoea—Dexamethasone—hematologic cancer	7.08e-05	0.000236	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Epirubicin—hematologic cancer	7.04e-05	0.000235	CcSEcCtD
Methyclothiazide—CA1—Metabolism—MTAP—hematologic cancer	6.96e-05	0.00152	CbGpPWpGaD
Methyclothiazide—Thrombocytopenia—Epirubicin—hematologic cancer	6.9e-05	0.00023	CcSEcCtD
Methyclothiazide—Dizziness—Betamethasone—hematologic cancer	6.84e-05	0.000229	CcSEcCtD
Methyclothiazide—Dizziness—Dexamethasone—hematologic cancer	6.84e-05	0.000229	CcSEcCtD
Methyclothiazide—Nausea—Triamcinolone—hematologic cancer	6.77e-05	0.000226	CcSEcCtD
Methyclothiazide—Paraesthesia—Methotrexate—hematologic cancer	6.76e-05	0.000226	CcSEcCtD
Methyclothiazide—CA4—Metabolism—FHL2—hematologic cancer	6.75e-05	0.00147	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	6.72e-05	0.00146	CbGpPWpGaD
Methyclothiazide—Anorexia—Epirubicin—hematologic cancer	6.71e-05	0.000224	CcSEcCtD
Methyclothiazide—Hypersensitivity—Prednisone—hematologic cancer	6.64e-05	0.000222	CcSEcCtD
Methyclothiazide—CA4—Metabolism—AGRN—hematologic cancer	6.62e-05	0.00144	CbGpPWpGaD
Methyclothiazide—Vomiting—Dexamethasone—hematologic cancer	6.58e-05	0.00022	CcSEcCtD
Methyclothiazide—Vomiting—Betamethasone—hematologic cancer	6.58e-05	0.00022	CcSEcCtD
Methyclothiazide—Decreased appetite—Methotrexate—hematologic cancer	6.54e-05	0.000219	CcSEcCtD
Methyclothiazide—Rash—Dexamethasone—hematologic cancer	6.52e-05	0.000218	CcSEcCtD
Methyclothiazide—Rash—Betamethasone—hematologic cancer	6.52e-05	0.000218	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Doxorubicin—hematologic cancer	6.52e-05	0.000218	CcSEcCtD
Methyclothiazide—Dermatitis—Dexamethasone—hematologic cancer	6.51e-05	0.000218	CcSEcCtD
Methyclothiazide—Dermatitis—Betamethasone—hematologic cancer	6.51e-05	0.000218	CcSEcCtD
Methyclothiazide—Headache—Dexamethasone—hematologic cancer	6.48e-05	0.000217	CcSEcCtD
Methyclothiazide—Headache—Betamethasone—hematologic cancer	6.48e-05	0.000217	CcSEcCtD
Methyclothiazide—CA2—Metabolism—FHL2—hematologic cancer	6.47e-05	0.00141	CbGpPWpGaD
Methyclothiazide—Asthenia—Prednisone—hematologic cancer	6.46e-05	0.000216	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Doxorubicin—hematologic cancer	6.38e-05	0.000213	CcSEcCtD
Methyclothiazide—CA2—Metabolism—AGRN—hematologic cancer	6.35e-05	0.00138	CbGpPWpGaD
Methyclothiazide—Paraesthesia—Epirubicin—hematologic cancer	6.33e-05	0.000211	CcSEcCtD
Methyclothiazide—CA4—Metabolism—HMMR—hematologic cancer	6.28e-05	0.00137	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—IDH2—hematologic cancer	6.28e-05	0.00137	CbGpPWpGaD
Methyclothiazide—Anorexia—Doxorubicin—hematologic cancer	6.21e-05	0.000208	CcSEcCtD
Methyclothiazide—CA1—Metabolism—FHL2—hematologic cancer	6.21e-05	0.00135	CbGpPWpGaD
Methyclothiazide—Diarrhoea—Prednisone—hematologic cancer	6.16e-05	0.000206	CcSEcCtD
Methyclothiazide—Nausea—Betamethasone—hematologic cancer	6.14e-05	0.000205	CcSEcCtD
Methyclothiazide—Nausea—Dexamethasone—hematologic cancer	6.14e-05	0.000205	CcSEcCtD
Methyclothiazide—Decreased appetite—Epirubicin—hematologic cancer	6.12e-05	0.000205	CcSEcCtD
Methyclothiazide—CA1—Metabolism—AGRN—hematologic cancer	6.09e-05	0.00133	CbGpPWpGaD
Methyclothiazide—Constipation—Epirubicin—hematologic cancer	6.02e-05	0.000201	CcSEcCtD
Methyclothiazide—CA2—Metabolism—IDH2—hematologic cancer	6.02e-05	0.00131	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—HMMR—hematologic cancer	6.02e-05	0.00131	CbGpPWpGaD
Methyclothiazide—Urticaria—Methotrexate—hematologic cancer	5.98e-05	0.0002	CcSEcCtD
Methyclothiazide—Dizziness—Prednisone—hematologic cancer	5.96e-05	0.000199	CcSEcCtD
Methyclothiazide—Body temperature increased—Methotrexate—hematologic cancer	5.95e-05	0.000199	CcSEcCtD
Methyclothiazide—CA4—Metabolism—ARNTL—hematologic cancer	5.9e-05	0.00129	CbGpPWpGaD
Methyclothiazide—Paraesthesia—Doxorubicin—hematologic cancer	5.85e-05	0.000196	CcSEcCtD
Methyclothiazide—CA1—Metabolism—HMMR—hematologic cancer	5.77e-05	0.00126	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—IDH2—hematologic cancer	5.77e-05	0.00126	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CA9—hematologic cancer	5.74e-05	0.00125	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ACP5—hematologic cancer	5.74e-05	0.00125	CbGpPWpGaD
Methyclothiazide—Vomiting—Prednisone—hematologic cancer	5.73e-05	0.000191	CcSEcCtD
Methyclothiazide—Rash—Prednisone—hematologic cancer	5.68e-05	0.00019	CcSEcCtD
Methyclothiazide—Dermatitis—Prednisone—hematologic cancer	5.67e-05	0.00019	CcSEcCtD
Methyclothiazide—CA4—Metabolism—NCOR2—hematologic cancer	5.67e-05	0.00123	CbGpPWpGaD
Methyclothiazide—Decreased appetite—Doxorubicin—hematologic cancer	5.67e-05	0.000189	CcSEcCtD
Methyclothiazide—CA2—Metabolism—ARNTL—hematologic cancer	5.66e-05	0.00123	CbGpPWpGaD
Methyclothiazide—Headache—Prednisone—hematologic cancer	5.64e-05	0.000189	CcSEcCtD
Methyclothiazide—Urticaria—Epirubicin—hematologic cancer	5.6e-05	0.000187	CcSEcCtD
Methyclothiazide—Constipation—Doxorubicin—hematologic cancer	5.57e-05	0.000186	CcSEcCtD
Methyclothiazide—Body temperature increased—Epirubicin—hematologic cancer	5.57e-05	0.000186	CcSEcCtD
Methyclothiazide—Hypersensitivity—Methotrexate—hematologic cancer	5.55e-05	0.000185	CcSEcCtD
Methyclothiazide—CA2—Metabolism—CA9—hematologic cancer	5.5e-05	0.0012	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ACP5—hematologic cancer	5.5e-05	0.0012	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NCOR2—hematologic cancer	5.43e-05	0.00118	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ARNTL—hematologic cancer	5.43e-05	0.00118	CbGpPWpGaD
Methyclothiazide—Asthenia—Methotrexate—hematologic cancer	5.4e-05	0.00018	CcSEcCtD
Methyclothiazide—CA4—Metabolism—IDH1—hematologic cancer	5.4e-05	0.00118	CbGpPWpGaD
Methyclothiazide—Nausea—Prednisone—hematologic cancer	5.35e-05	0.000179	CcSEcCtD
Methyclothiazide—CA4—Metabolism—GSTO1—hematologic cancer	5.34e-05	0.00116	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ABCC3—hematologic cancer	5.34e-05	0.00116	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—TXN—hematologic cancer	5.34e-05	0.00116	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ACP5—hematologic cancer	5.28e-05	0.00115	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CA9—hematologic cancer	5.28e-05	0.00115	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—SPHK1—hematologic cancer	5.22e-05	0.00114	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NCOR2—hematologic cancer	5.21e-05	0.00113	CbGpPWpGaD
Methyclothiazide—Hypersensitivity—Epirubicin—hematologic cancer	5.19e-05	0.000173	CcSEcCtD
Methyclothiazide—Urticaria—Doxorubicin—hematologic cancer	5.18e-05	0.000173	CcSEcCtD
Methyclothiazide—CA2—Metabolism—IDH1—hematologic cancer	5.18e-05	0.00113	CbGpPWpGaD
Methyclothiazide—Body temperature increased—Doxorubicin—hematologic cancer	5.15e-05	0.000172	CcSEcCtD
Methyclothiazide—Diarrhoea—Methotrexate—hematologic cancer	5.15e-05	0.000172	CcSEcCtD
Methyclothiazide—CA2—Metabolism—ABCC3—hematologic cancer	5.12e-05	0.00111	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GSTO1—hematologic cancer	5.12e-05	0.00111	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—TXN—hematologic cancer	5.12e-05	0.00111	CbGpPWpGaD
Methyclothiazide—Asthenia—Epirubicin—hematologic cancer	5.05e-05	0.000169	CcSEcCtD
Methyclothiazide—CA4—Metabolism—UGT1A1—hematologic cancer	5.02e-05	0.00109	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—SPHK1—hematologic cancer	5.01e-05	0.00109	CbGpPWpGaD
Methyclothiazide—Dizziness—Methotrexate—hematologic cancer	4.98e-05	0.000166	CcSEcCtD
Methyclothiazide—CA1—Metabolism—IDH1—hematologic cancer	4.96e-05	0.00108	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.95e-05	0.00108	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—TXN—hematologic cancer	4.91e-05	0.00107	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ABCC3—hematologic cancer	4.91e-05	0.00107	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GSTO1—hematologic cancer	4.91e-05	0.00107	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—SLC22A1—hematologic cancer	4.88e-05	0.00106	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CRABP1—hematologic cancer	4.88e-05	0.00106	CbGpPWpGaD
Methyclothiazide—Diarrhoea—Epirubicin—hematologic cancer	4.82e-05	0.000161	CcSEcCtD
Methyclothiazide—CA2—Metabolism—UGT1A1—hematologic cancer	4.81e-05	0.00105	CbGpPWpGaD
Methyclothiazide—Hypersensitivity—Doxorubicin—hematologic cancer	4.8e-05	0.00016	CcSEcCtD
Methyclothiazide—CA1—Metabolism—SPHK1—hematologic cancer	4.8e-05	0.00105	CbGpPWpGaD
Methyclothiazide—Vomiting—Methotrexate—hematologic cancer	4.79e-05	0.00016	CcSEcCtD
Methyclothiazide—CA4—Metabolism—ALOX5—hematologic cancer	4.76e-05	0.00104	CbGpPWpGaD
Methyclothiazide—Rash—Methotrexate—hematologic cancer	4.75e-05	0.000159	CcSEcCtD
Methyclothiazide—Dermatitis—Methotrexate—hematologic cancer	4.74e-05	0.000158	CcSEcCtD
Methyclothiazide—Headache—Methotrexate—hematologic cancer	4.72e-05	0.000158	CcSEcCtD
Methyclothiazide—CA2—Metabolism—SLC22A1—hematologic cancer	4.68e-05	0.00102	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CRABP1—hematologic cancer	4.68e-05	0.00102	CbGpPWpGaD
Methyclothiazide—Asthenia—Doxorubicin—hematologic cancer	4.68e-05	0.000156	CcSEcCtD
Methyclothiazide—Dizziness—Epirubicin—hematologic cancer	4.66e-05	0.000156	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.63e-05	0.00101	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—UGT1A1—hematologic cancer	4.61e-05	0.001	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NUP98—hematologic cancer	4.61e-05	0.001	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ALOX5—hematologic cancer	4.56e-05	0.000994	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.49e-05	0.000979	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—SLC22A1—hematologic cancer	4.49e-05	0.000978	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CRABP1—hematologic cancer	4.49e-05	0.000978	CbGpPWpGaD
Methyclothiazide—Vomiting—Epirubicin—hematologic cancer	4.48e-05	0.00015	CcSEcCtD
Methyclothiazide—CA4—Metabolism—ADCY7—hematologic cancer	4.47e-05	0.000975	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NCOA3—hematologic cancer	4.47e-05	0.000975	CbGpPWpGaD
Methyclothiazide—Nausea—Methotrexate—hematologic cancer	4.47e-05	0.000149	CcSEcCtD
Methyclothiazide—Diarrhoea—Doxorubicin—hematologic cancer	4.46e-05	0.000149	CcSEcCtD
Methyclothiazide—Rash—Epirubicin—hematologic cancer	4.44e-05	0.000148	CcSEcCtD
Methyclothiazide—CA4—Metabolism—NUP214—hematologic cancer	4.44e-05	0.000968	CbGpPWpGaD
Methyclothiazide—Dermatitis—Epirubicin—hematologic cancer	4.44e-05	0.000148	CcSEcCtD
Methyclothiazide—CA2—Metabolism—NUP98—hematologic cancer	4.42e-05	0.000962	CbGpPWpGaD
Methyclothiazide—Headache—Epirubicin—hematologic cancer	4.41e-05	0.000147	CcSEcCtD
Methyclothiazide—CA1—Metabolism—ALOX5—hematologic cancer	4.37e-05	0.000953	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—MTR—hematologic cancer	4.35e-05	0.000948	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ABCG2—hematologic cancer	4.35e-05	0.000948	CbGpPWpGaD
Methyclothiazide—Dizziness—Doxorubicin—hematologic cancer	4.31e-05	0.000144	CcSEcCtD
Methyclothiazide—CA2—Metabolism—ADCY7—hematologic cancer	4.29e-05	0.000934	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NCOA3—hematologic cancer	4.29e-05	0.000934	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ENO2—hematologic cancer	4.27e-05	0.00093	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NUP214—hematologic cancer	4.26e-05	0.000928	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NUP98—hematologic cancer	4.24e-05	0.000923	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ALB—hematologic cancer	4.2e-05	0.000916	CbGpPWpGaD
Methyclothiazide—Nausea—Epirubicin—hematologic cancer	4.18e-05	0.00014	CcSEcCtD
Methyclothiazide—CA2—Metabolism—MTR—hematologic cancer	4.17e-05	0.000909	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ABCG2—hematologic cancer	4.17e-05	0.000909	CbGpPWpGaD
Methyclothiazide—Vomiting—Doxorubicin—hematologic cancer	4.14e-05	0.000138	CcSEcCtD
Methyclothiazide—CA4—Metabolism—GSTT1—hematologic cancer	4.14e-05	0.000902	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ADCY7—hematologic cancer	4.11e-05	0.000896	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NCOA3—hematologic cancer	4.11e-05	0.000896	CbGpPWpGaD
Methyclothiazide—Rash—Doxorubicin—hematologic cancer	4.11e-05	0.000137	CcSEcCtD
Methyclothiazide—Dermatitis—Doxorubicin—hematologic cancer	4.11e-05	0.000137	CcSEcCtD
Methyclothiazide—CA2—Metabolism—ENO2—hematologic cancer	4.09e-05	0.000891	CbGpPWpGaD
Methyclothiazide—Headache—Doxorubicin—hematologic cancer	4.08e-05	0.000136	CcSEcCtD
Methyclothiazide—CA1—Metabolism—NUP214—hematologic cancer	4.08e-05	0.000889	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—SDC1—hematologic cancer	4.05e-05	0.000881	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ABCG2—hematologic cancer	4e-05	0.000871	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—MTR—hematologic cancer	4e-05	0.000871	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GSTT1—hematologic cancer	3.97e-05	0.000864	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ENO2—hematologic cancer	3.92e-05	0.000855	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—SDC1—hematologic cancer	3.88e-05	0.000845	CbGpPWpGaD
Methyclothiazide—Nausea—Doxorubicin—hematologic cancer	3.87e-05	0.000129	CcSEcCtD
Methyclothiazide—CA1—Metabolism—GSTT1—hematologic cancer	3.8e-05	0.000829	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—SDC1—hematologic cancer	3.72e-05	0.00081	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CD44—hematologic cancer	3.44e-05	0.000749	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NQO1—hematologic cancer	3.44e-05	0.000749	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NQO1—hematologic cancer	3.3e-05	0.000718	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CD44—hematologic cancer	3.3e-05	0.000718	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CYCS—hematologic cancer	3.25e-05	0.000709	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—HSP90AA1—hematologic cancer	3.23e-05	0.000705	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CD44—hematologic cancer	3.16e-05	0.000689	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NQO1—hematologic cancer	3.16e-05	0.000689	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYCS—hematologic cancer	3.12e-05	0.00068	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—HSP90AA1—hematologic cancer	3.1e-05	0.000675	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CYCS—hematologic cancer	2.99e-05	0.000652	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—HSP90AA1—hematologic cancer	2.97e-05	0.000648	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GSTP1—hematologic cancer	2.87e-05	0.000625	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GSTP1—hematologic cancer	2.75e-05	0.000599	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ABCB1—hematologic cancer	2.72e-05	0.000592	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GSTP1—hematologic cancer	2.64e-05	0.000574	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NCOR1—hematologic cancer	2.64e-05	0.000574	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GSTM1—hematologic cancer	2.64e-05	0.000574	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ABCB1—hematologic cancer	2.6e-05	0.000567	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GSTM1—hematologic cancer	2.53e-05	0.000551	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NCOR1—hematologic cancer	2.53e-05	0.000551	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ABCB1—hematologic cancer	2.5e-05	0.000544	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GSTM1—hematologic cancer	2.42e-05	0.000528	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NCOR1—hematologic cancer	2.42e-05	0.000528	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—MTHFR—hematologic cancer	2.33e-05	0.000508	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—MTHFR—hematologic cancer	2.23e-05	0.000487	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—MTHFR—hematologic cancer	2.14e-05	0.000467	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PIK3CG—hematologic cancer	1.96e-05	0.000426	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PIK3CG—hematologic cancer	1.88e-05	0.000409	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CREBBP—hematologic cancer	1.81e-05	0.000395	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PIK3CG—hematologic cancer	1.8e-05	0.000392	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CREBBP—hematologic cancer	1.74e-05	0.000379	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PIK3CD—hematologic cancer	1.72e-05	0.000375	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ALB—hematologic cancer	1.7e-05	0.00037	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CREBBP—hematologic cancer	1.67e-05	0.000363	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PIK3CD—hematologic cancer	1.65e-05	0.000359	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ALB—hematologic cancer	1.63e-05	0.000355	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PIK3R1—hematologic cancer	1.62e-05	0.000354	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PIK3CD—hematologic cancer	1.58e-05	0.000345	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ALB—hematologic cancer	1.56e-05	0.00034	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PIK3R1—hematologic cancer	1.56e-05	0.000339	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PIK3CB—hematologic cancer	1.5e-05	0.000327	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PIK3R1—hematologic cancer	1.49e-05	0.000325	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PIK3CB—hematologic cancer	1.44e-05	0.000313	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PIK3CB—hematologic cancer	1.38e-05	0.0003	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PTEN—hematologic cancer	1.3e-05	0.000282	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PTEN—hematologic cancer	1.24e-05	0.000271	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—EP300—hematologic cancer	1.24e-05	0.000269	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PTEN—hematologic cancer	1.19e-05	0.00026	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—EP300—hematologic cancer	1.19e-05	0.000258	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—EP300—hematologic cancer	1.14e-05	0.000248	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PIK3CA—hematologic cancer	9.14e-06	0.000199	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PIK3CA—hematologic cancer	8.77e-06	0.000191	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PIK3CA—hematologic cancer	8.4e-06	0.000183	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—AKT1—hematologic cancer	7.47e-06	0.000163	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—AKT1—hematologic cancer	7.16e-06	0.000156	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—AKT1—hematologic cancer	6.87e-06	0.00015	CbGpPWpGaD
